Provided by Tiger Fintech (Singapore) Pte. Ltd.

PharmaCyte Biotech, Inc.

1.01
0.0000
Post-market: 1.00-0.0100-0.99%17:54 EDT
Volume:16.52K
Turnover:16.92K
Market Cap:6.94M
PE:0.78
High:1.03
Open:1.00
Low:1.00
Close:1.01
Loading ...
Apr 24, 2025

Major Issues Report

Form 8-K - Current report
Mar 17, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 26, 2025

Major Issues Report

Form 8-K - Current report
Dec 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dec 04, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Sep 17, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 13, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
May 31, 2024

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
May 23, 2024

Major Issues Report

Form 8-K - Current report
May 02, 2024

Major Issues Report

Form 8-K - Current report
Mar 18, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 06, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Dec 16, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 25, 2023

Major Issues Report

Form 8-K - Current report
Nov 23, 2023

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Nov 16, 2023

Major Issues Report

Form 8-K - Current report
Nov 10, 2023

Major Issues Report

Form 8-K - Current report
Sep 28, 2023

Correspondence

Form CORRESP - Correspondence